vs
GE医疗(DHC)与UiPath, Inc.(PATH)财务数据对比。点击上方公司名可切换其他公司
UiPath, Inc.的季度营收约是GE医疗的1.1倍($411.1M vs $379.6M),UiPath, Inc.净利率更高(48.4% vs -5.6%,领先54.0%),UiPath, Inc.同比增速更快(15.9% vs -0.0%),UiPath, Inc.自由现金流更多($25.1M vs $-166.4M),过去两年GE医疗的营收复合增速更高(1.2% vs 0.7%)
GE医疗是一家总部位于美国伊利诺伊州芝加哥市的医疗科技企业,业务涵盖四大板块:医疗影像设备,包括分子成像、CT、核磁共振、妇科健康筛查及X光系统;超声设备;患者护理解决方案,聚焦远程患者监测、麻醉呼吸护理、心脏诊断及婴幼儿护理;此外还涉及医药相关领域,是全球医疗行业的知名企业。
UiPath是一家全球化软件企业,专注于开发人工智能、智能自动化及流程编排类软件,其产品支持用户搭建与调度AI代理,实现复杂业务流程、工作流的自动化运行,助力各行业客户提升运营效率、降低人力成本。
DHC vs PATH — 直观对比
营收规模更大
PATH
是对方的1.1倍
$379.6M
营收增速更快
PATH
高出15.9%
-0.0%
净利率更高
PATH
高出54.0%
-5.6%
自由现金流更多
PATH
多$191.5M
$-166.4M
两年增速更快
DHC
近两年复合增速
0.7%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $379.6M | $411.1M |
| 净利润 | $-21.2M | $198.8M |
| 毛利率 | — | 83.3% |
| 营业利润率 | -12.6% | 3.2% |
| 净利率 | -5.6% | 48.4% |
| 营收同比 | -0.0% | 15.9% |
| 净利润同比 | 75.7% | 1966.2% |
| 每股收益(稀释后) | $-0.09 | $0.37 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
DHC
PATH
| Q4 25 | $379.6M | $411.1M | ||
| Q3 25 | $388.7M | $361.7M | ||
| Q2 25 | $382.7M | $356.6M | ||
| Q1 25 | $386.9M | $423.6M | ||
| Q4 24 | $379.6M | $354.7M | ||
| Q3 24 | $373.6M | $316.3M | ||
| Q2 24 | $371.4M | $335.1M | ||
| Q1 24 | $370.8M | $405.3M |
净利润
DHC
PATH
| Q4 25 | $-21.2M | $198.8M | ||
| Q3 25 | $-164.0M | $1.6M | ||
| Q2 25 | $-91.6M | $-22.6M | ||
| Q1 25 | $-9.0M | $51.8M | ||
| Q4 24 | $-87.4M | $-10.7M | ||
| Q3 24 | $-98.7M | $-86.1M | ||
| Q2 24 | $-97.9M | $-28.7M | ||
| Q1 24 | $-86.3M | $33.9M |
毛利率
DHC
PATH
| Q4 25 | — | 83.3% | ||
| Q3 25 | — | 82.2% | ||
| Q2 25 | — | 82.1% | ||
| Q1 25 | — | 84.8% | ||
| Q4 24 | — | 82.0% | ||
| Q3 24 | — | 80.0% | ||
| Q2 24 | — | 83.5% | ||
| Q1 24 | — | 86.8% |
营业利润率
DHC
PATH
| Q4 25 | -12.6% | 3.2% | ||
| Q3 25 | -43.4% | -5.6% | ||
| Q2 25 | -24.5% | -4.6% | ||
| Q1 25 | -2.7% | 7.9% | ||
| Q4 24 | -26.1% | -12.2% | ||
| Q3 24 | -26.5% | -32.7% | ||
| Q2 24 | -23.0% | -14.8% | ||
| Q1 24 | -23.7% | 3.7% |
净利率
DHC
PATH
| Q4 25 | -5.6% | 48.4% | ||
| Q3 25 | -42.2% | 0.4% | ||
| Q2 25 | -23.9% | -6.3% | ||
| Q1 25 | -2.3% | 12.2% | ||
| Q4 24 | -23.0% | -3.0% | ||
| Q3 24 | -26.4% | -27.2% | ||
| Q2 24 | -26.3% | -8.6% | ||
| Q1 24 | -23.3% | 8.4% |
每股收益(稀释后)
DHC
PATH
| Q4 25 | $-0.09 | $0.37 | ||
| Q3 25 | $-0.68 | $0.00 | ||
| Q2 25 | $-0.38 | $-0.04 | ||
| Q1 25 | $-0.04 | $0.09 | ||
| Q4 24 | $-0.37 | $-0.02 | ||
| Q3 24 | $-0.41 | $-0.15 | ||
| Q2 24 | $-0.41 | $-0.05 | ||
| Q1 24 | $-0.36 | $0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $105.4M | $1.4B |
| 总债务越低越好 | $2.4B | — |
| 股东权益账面价值 | $1.7B | $1.9B |
| 总资产 | $4.4B | $2.9B |
| 负债/权益比越低杠杆越低 | 1.47× | — |
8季度趋势,按日历期对齐
现金及短期投资
DHC
PATH
| Q4 25 | $105.4M | $1.4B | ||
| Q3 25 | $201.4M | $1.4B | ||
| Q2 25 | $141.8M | $1.6B | ||
| Q1 25 | $302.6M | $1.6B | ||
| Q4 24 | $144.6M | $1.6B | ||
| Q3 24 | $256.5M | $1.7B | ||
| Q2 24 | $265.6M | $1.9B | ||
| Q1 24 | $207.1M | $1.9B |
总债务
DHC
PATH
| Q4 25 | $2.4B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $3.1B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
DHC
PATH
| Q4 25 | $1.7B | $1.9B | ||
| Q3 25 | $1.7B | $1.7B | ||
| Q2 25 | $1.9B | $1.7B | ||
| Q1 25 | $1.9B | $1.8B | ||
| Q4 24 | $2.0B | $1.7B | ||
| Q3 24 | $2.0B | $1.8B | ||
| Q2 24 | $2.1B | $2.0B | ||
| Q1 24 | $2.2B | $2.0B |
总资产
DHC
PATH
| Q4 25 | $4.4B | $2.9B | ||
| Q3 25 | $4.7B | $2.6B | ||
| Q2 25 | $4.8B | $2.6B | ||
| Q1 25 | $5.0B | $2.9B | ||
| Q4 24 | $5.1B | $2.7B | ||
| Q3 24 | $5.3B | $2.7B | ||
| Q2 24 | $5.3B | $2.8B | ||
| Q1 24 | $5.3B | $3.0B |
负债/权益比
DHC
PATH
| Q4 25 | 1.47× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.56× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-19.6M | $28.3M |
| 自由现金流经营现金流 - 资本支出 | $-166.4M | $25.1M |
| 自由现金流率自由现金流/营收 | -43.8% | 6.1% |
| 资本支出强度资本支出/营收 | 38.7% | 0.8% |
| 现金转化率经营现金流/净利润 | — | 0.14× |
| 过去12个月自由现金流最近4个季度 | $-280.3M | — |
8季度趋势,按日历期对齐
经营现金流
DHC
PATH
| Q4 25 | $-19.6M | $28.3M | ||
| Q3 25 | $-49.3M | $41.6M | ||
| Q2 25 | $53.0M | $119.0M | ||
| Q1 25 | $-3.2M | $146.1M | ||
| Q4 24 | $112.2M | $28.1M | ||
| Q3 24 | $21.1M | $46.4M | ||
| Q2 24 | $44.3M | $100.0M | ||
| Q1 24 | $28.6M | $145.6M |
自由现金流
DHC
PATH
| Q4 25 | $-166.4M | $25.1M | ||
| Q3 25 | $-89.8M | — | ||
| Q2 25 | $18.8M | $106.2M | ||
| Q1 25 | $-42.9M | $138.7M | ||
| Q4 24 | $-89.5M | $23.2M | ||
| Q3 24 | $-26.1M | $45.0M | ||
| Q2 24 | $3.3M | $98.8M | ||
| Q1 24 | $-18.1M | $141.8M |
自由现金流率
DHC
PATH
| Q4 25 | -43.8% | 6.1% | ||
| Q3 25 | -23.1% | — | ||
| Q2 25 | 4.9% | 29.8% | ||
| Q1 25 | -11.1% | 32.7% | ||
| Q4 24 | -23.6% | 6.5% | ||
| Q3 24 | -7.0% | 14.2% | ||
| Q2 24 | 0.9% | 29.5% | ||
| Q1 24 | -4.9% | 35.0% |
资本支出强度
DHC
PATH
| Q4 25 | 38.7% | 0.8% | ||
| Q3 25 | 10.4% | 0.0% | ||
| Q2 25 | 8.9% | 3.6% | ||
| Q1 25 | 10.2% | 1.7% | ||
| Q4 24 | 53.1% | 1.4% | ||
| Q3 24 | 12.6% | 0.4% | ||
| Q2 24 | 11.0% | 0.4% | ||
| Q1 24 | 12.6% | 0.9% |
现金转化率
DHC
PATH
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 26.25× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 2.82× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 4.29× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DHC
| Senior Housing Operating Portfolio Segment | $323.4M | 85% |
| Rental Income | $56.2M | 15% |
PATH
| Subscription Services | $247.6M | 60% |
| License | $150.0M | 36% |
| Professional Services And Other | $13.5M | 3% |